HUMT — Humatech Share Price
- $0.01m
- $0.71m
- $1.57m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.01 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -32.77% |
Financial Summary
Year End 30th Apr | Unit | 2002 | 2003 | 2004 | 2005 | 2006 | 2007E | 2008E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0.17 | 0.24 | 0.28 | 0.72 | 1.57 | n/a | n/a | 51.84% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Humatech, Inc. produces and distributes humate-based trace element fertilizers and animal feed products. The Company manufactures and distributes mineral-based animal feed supplements to the animal feeding industry. It also manufactures and distributes organic-based fertilizer products to two primary groups: commercial growers of agricultural crops, and mass merchandisers and independent nurseries in the retail lawn and garden market. The Company’s animal feed ingredients by species include swine, beef, dairy, poultry and aquaculture. The Company’s animal feed ingredients by products include DPX 9902, Proxmax and Private Label. In the agriculture category, the Company offers AgriHume, Maximize, Nitro Plus, Macro Plus and Calcium Plus. The Company’s products are sold to agriculture products’ dealers/distributors, retail customers as well as livestock feedlot operators, ranchers and other agricultural customers throughout the United States.
Directors
- Last Annual
- April 30th, 2006
- Last Interim
- July 31st, 2006
- Incorporated
- February 2nd, 1988
- Public Since
- February 29th, 2000
- No. of Shareholders
- 181
- No. of Employees
- 11
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 95,000,000

- Address
- 19416 Park Row, Suite 170,, HOUSTON, 77084
- Web
- http://www.humatech.com/
- Phone
- +1 8323213098
- Auditors
- Epstein, Weber & Conover, PLC
Similar to HUMT
Advanced Container Technologies
Pink Sheets on Nasdaq
Alkane
Pink Sheets on Nasdaq
Angstrom Technologies
Pink Sheets on Nasdaq
Asia Carbon Industries
Pink Sheets on Nasdaq
BioLargo
Pink Sheets on Nasdaq
FAQ
As of Today at 21:10 UTC, shares in Humatech are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Humatech last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Humatech share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out moreHumatech does not currently pay a dividend.
Humatech does not currently pay a dividend.
Humatech does not currently pay a dividend.
To buy shares in Humatech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Humatech had a market capitalisation of $0.01m.
Here are the trading details for Humatech:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HUMT
Based on an overall assessment of its quality, value and momentum Humatech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Humatech. Over the past six months, its share price has outperformed the S&P500 Index by +10251.48%.
As of the last closing price of $0.00, shares in Humatech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Humatech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Humatech's management team is headed by:
- David Williams - PRE
- John Rottweiler - CFO